Medipharm Labs (Otc) (TSE:LABS) has released an update.
MediPharm Labs, a leader in pharmaceutical-quality cannabis concentrates, has reported a significant 50% increase in annual revenue and adjusted EBITDA as per its latest full year and fourth quarter financial results for 2023. A conference call discussing these results was held, with a replay available for those who missed the live discussion. The company plans to continue its investor engagement with an upcoming conference call scheduled in May 2024 to discuss first quarter earnings.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.
